ANDA 76375, held by Chartwell Rx. Rimantadine Hydrochloride.
As of Nov 16, 2026, ANDA 76375 (Rimantadine Hydrochloride), held by Chartwell Rx, was first approved by FDA on Jan 14, 2003, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jan 14, 2003 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Rimantadine Hydrochloride100MG ยท tablet;oral | Rimantadine Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters